Usefulness of the CHAMPS score for risk stratification in lower gastrointestinal bleeding

Munehiko Tajika1, Tamotsu Matsuhashi1, Yosuke Shimodaira2

  • 1Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.

Scientific Reports
|May 9, 2022
PubMed

Insights

The CHAMPS score effectively predicts in-hospital mortality in lower gastrointestinal bleeding (LGIB) patients. This validated score offers a reliable tool for assessing mortality risk in LGIB cases.

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Predictive Analytics

Background:

  • In-hospital mortality prediction is crucial for managing lower gastrointestinal bleeding (LGIB).
  • Existing prediction scores often lack specific validation for LGIB patient populations.

Purpose of the Study:

  • To evaluate the utility of the CHAMPS score, initially developed for upper gastrointestinal bleeding, in predicting in-hospital mortality among patients with LGIB.
  • To compare the predictive performance of the CHAMPS score against established risk stratification tools in LGIB.

Main Methods:

  • Retrospective analysis of consecutive adult patients hospitalized with LGIB between 2015 and 2020 at two tertiary academic medical centers.
  • Performance assessment using receiver operating characteristic (ROC) curve analysis to determine the area under the curve (AUC).
  • Comparison of CHAMPS score performance against four pre-existing risk scores.

Main Results:

  • The study included 387 patients, with 39 (10.1%) experiencing in-hospital mortality.
  • The CHAMPS score demonstrated strong predictive performance for in-hospital mortality in LGIB patients, achieving an AUC of 0.80 (95% CI: 0.73-0.87).
  • CHAMPS score significantly outperformed existing scores, with distinct risk categories identified: low risk (≤1) 1.8%, intermediate risk (2 or 3) 15.8%, and high risk (≥4) 37.1% mortality.

Conclusions:

  • The CHAMPS score is a valuable and effective tool for predicting in-hospital mortality in patients diagnosed with lower gastrointestinal bleeding.
  • The validated performance of the CHAMPS score in an LGIB cohort supports its clinical utility for risk stratification and patient management.